TY  - JOUR
AU  - Melguizo, Consolación
AU  - Prados, José
AU  - Luque, Raquel
AU  - Ortiz, Raúl
AU  - Caba, Octavio
AU  - Álvarez, Pablo J
AU  - Gonzalez, Bestriz
AU  - Aranega, Antonia
PY  - 2012
DO  - 10.3390/ijms131216624
UR  - http://hdl.handle.net/10668/774
T2  - International Journal of Molecular Sciences
AB  - Carboplatin-paclitaxel is a reference regimen in the treatment of locally advanced or disseminated non-small cell lung cancer (NSCLC). This paper discusses the multidrug resistance developed with this drug combination, which is one of the major...
LA  - en
PB  - MDPI
KW  - resistance
KW  - lung cancer
KW  - MDR
KW  - MRP
KW  - paclitaxel
KW  - carboplatin
KW  - Genes MDR
KW  - Neoplasias Pulmonares
KW  - Resistencia a Antineoplásicos
KW  - Medical Subject Headings::Phenomena and Processes::Genetic Phenomena::Genetic Structures::Genome::Genome Components::Genes::Genes, MDR
KW  - Medical Subject Headings::Chemicals and Drugs::Organic Chemicals::Hydrocarbons::Hydrocarbons, Cyclic::Hydrocarbons, Alicyclic::Cycloparaffins::Cyclodecanes::Taxoids::Paclitaxel
KW  - Medical Subject Headings::Chemicals and Drugs::Organic Chemicals::Organometallic Compounds::Organoplatinum Compounds::Carboplatin
KW  - Medical Subject Headings::Diseases::Neoplasms::Neoplasms by Site::Thoracic Neoplasms::Respiratory Tract Neoplasms::Lung Neoplasms
KW  - Medical Subject Headings::Phenomena and Processes::Physiological Phenomena::Pharmacological Phenomena::Drug Resistance::Drug Resistance, Neoplasm
TI  - Modulation of MDR1 and MRP3 Gene Expression in Lung Cancer Cells after Paclitaxel and Carboplatin Exposure
TY  - research article
ER  -